AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

aap Implantate AG

Related Party Transaction Mar 3, 2006

10_rns_2006-03-03_7bbf1b15-be66-4524-b5d9-15832e01e164.html

Related Party Transaction

Open in Viewer

Opens in native device viewer

News Details

Corporate | 3 March 2006 15:24

aap Implantate AG: Heraeus distributes biomaterial Ostim

Corporate-news transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. —————————————————————————— Heraeus distributes biomaterial Ostim Berlin, March 3, 2006 ADC Advanced Dental Care, a subsidiary of aap Implantate AG, a German medical technology company active in the areas of fracture healing, joint replacement, bone cements and biomaterials, has entered into a long-term agreement with Heraeus Kulzer GmbH for the worldwide distribution of aap´s bone graft substitute Ostim in the dental field. Heraeus Kulzer, a subsidiary of the Heraeus Group, is a leading European supplier of dental products. Ostim is a synthetic nanotechnology-based, absorbable bone graft substitute. Nanostructure, revascularization and bone transformation quality of Ostim extensively corresponds to the quality of the natural bone. This agreement, which significantly enlarges an existing cooperation, also includes the market introduction of Ostim in the dental field in the USA. The FDA approval required for this has already been obtained. After a one-year introductory phase, the target minimum sales volume of the cooperation is significantly above one million Euros per year for ADC and should further increase in coming years. In October 2005 aap Implantate AG acquired 54% of ADC´s shares. Contact: For further Information, please contact: aap Implantate AG; Nanette Hüdepohl; Investor & Public Relations; Lorenzweg 5; D-12099 Berlin Tel.: ++49/30/750 19 – 133; Fax.: ++49/30/750 19 – 290; [email protected] (c)DGAP 03.03.2006 ————————————————————————— language: English emitter: aap Implantate AG Lorenzweg 5 12099 Berlin Deutschland phone: +49 (0) 30 75 01 90 fax: +49 (0) 30 75 01 91 11 email: [email protected] WWW: www.aap.de ISIN: DE0005066609 WKN: 506660 indexes: stockmarkets: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin-Bremen, Hannover, Düsseldorf, Hamburg, München, Stuttgart End of News DGAP News-Service —————————————————————————

Talk to a Data Expert

Have a question? We'll get back to you promptly.